PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
115 hedge funds and large institutions have $99.9M invested in Provention Bio, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+2
Holders Change %
+1.77%
% of All Funds
1.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
32
Reduced
28
Closed
19
Calls
$3.17M
Puts
$842K
Net Calls
+$2.32M
Net Calls Change
-$4.07M
Top Buyers
| 1 |
MB
1
MPM BioImpact
Boston,
Massachusetts
|
$2.37M |
| 2 |
2
BlackRock
New York
|
$18.4M |
| 3 |
3
Adage Capital Partners
Boston,
Massachusetts
|
$3.6M |
| 4 |
4
Renaissance Technologies
New York
|
$667K |
| 5 |
DCM
5
DG Capital Management
New York
|
$2.49M |
